Humana IncHUM
Price$379.68Intrinsic value$367.843% below price

Outlook & Key Dates

Estimates, guidance, catalysts, and upcoming events

Analyst Estimates Learn more →
5-Yr Fwd EPS Growth
17.4%projected annual EPS growth
As of 27 Aug 2026
Analyst Coverage
23analysts covering
Consensus: PositiveAs of 18 Aug 2026
FY EPS (est.)
$9.15next fiscal year
As of 18 Aug 2026
Monitoring Framework
Key Performance Indicators
Medical Benefit Ratio (MBR) Quarterly92.8%Target: 92.75% plus or minus 25 basis points for FY 2026
Individual Medicare Advantage (MA) Membership Growth Annually25.0%Target: Approximately 25% growth over 2025
Medicare Advantage Margin AnnuallyTarget: 3.0%+
Watch Items
  • CMS Medicare Advantage Rate DecisionsTrigger: Rate increases below expected medical cost trend inflationAction: Adjust plan pricing, benefit designs, and geographic footprint to prioritize margin over membership growth.
  • Medicare Advantage Star RatingsTrigger: Percentage of members in 4-star or higher plans dropping significantly below historical levels (e.g., near 25%)Action: Enhance clinical compliance, documentation, and quality improvement programs to regain bonus payments.
  • Activist Investor Pressure (Glenview Capital)Trigger: Public demands for board seats or strategic changesAction: Engage in constructive dialogue, accelerate operational discipline, and execute on the multi-year margin recovery plan.
Sign in / Sign up to read more

Research as of 2 Sep 2026

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.